These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2934942)

  • 1. [Anti-slow reacting substance of anaphylaxis effect of verapamil].
    Zhang HQ; Bian RL
    Zhongguo Yao Li Xue Bao; 1985 Jun; 6(2):110-2. PubMed ID: 2934942
    [No Abstract]   [Full Text] [Related]  

  • 2. [The anti-SRS-A effect of tetrandrine].
    Zhang HQ; Bian RL
    Yao Xue Xue Bao; 1984 Aug; 19(8):616-8. PubMed ID: 6536169
    [No Abstract]   [Full Text] [Related]  

  • 3. Unique modulation of the immunological release of slow-reacting substance of anaphylaxis (SRS-A) from bovine lung.
    Burka JF; Eyre P
    Monogr Allergy; 1977; 12():241-4. PubMed ID: 335217
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on slow reacting substance (SRS). Comparison of naturally occurring, radiolabeled SRS and synthetic leukotriene D4 (LTD4) on high performance liquid chromatography, and of partially purified SRS-A and LTD4 on the activity of smooth muscle preparations of guinea pig].
    Watanabe-Kohno S; Kiso S; Ohata K
    Arerugi; 1983 Jan; 32(1):46-56. PubMed ID: 6134518
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological properties of the orally active leukotriene antagonist [[5-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propyl]thio]-1,3,4- thiadiazol-2-yl]thio]acetic acid.
    Tomioka K; Yamada T; Mase T; Hara H; Murase K
    Arzneimittelforschung; 1988 May; 38(5):682-5. PubMed ID: 3415708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of slow reacting substance of anaphylaxins (SRS-A) by arylsulfatases.
    Orange RP; Murphy RC; Austen KF
    J Immunol; 1974 Jul; 113(1):316-22. PubMed ID: 4832311
    [No Abstract]   [Full Text] [Related]  

  • 7. Further studies on the inactivation of slow-reacting substance of anaphylaxis by lipoxidase.
    Sirois P
    Adv Prostaglandin Thromboxane Res; 1980; 6():125-8. PubMed ID: 6770589
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of verapamil and propranolol on bronchoconstriction induced by leukotriene D4 in the isolated perfused guinea pig lung].
    Trockle G; Catau G; Febvre N; Kalt C; Jacque M
    J Pharmacol; 1985; 16(4):454-8. PubMed ID: 4094440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory action of verapamil and chlorpromazine on the release of slow-reacting substance of anaphylaxis from cat lung.
    Dell'Osa D; Temple DM
    Pharmacol Res Commun; 1986 Nov; 18(11):1043-52. PubMed ID: 2432620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypothesis on the inactivation mechanism of slow reacting substance of anaphylaxis (SRS-A)].
    Sirois P; Borgeat P
    Union Med Can; 1980 Nov; 109(11):1642-6. PubMed ID: 6782731
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of slow-reacting substance in asthma.
    Brocklehurst WE
    Adv Drug Res; 1970; 5():109-13. PubMed ID: 4923800
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metabolism and effects of vasoactive substance in the lung. 10. Effects of calcium antagonist, verapamil, on the smooth muscle of the trachea].
    Ishihara Y; Shimizu T; Sasaki K; Kitamura S; Kosaka K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1976 Sep; 14(9):506-11. PubMed ID: 1033404
    [No Abstract]   [Full Text] [Related]  

  • 13. Slow reacting substance of anaphylaxis enhances the generation of 12-L-hydroxy-5,8,10,14-eicosa- tetraenoic acid in isolated lungs.
    Omini C; Sautebin L; Galli G; Folco GC; Berti F
    Adv Prostaglandin Thromboxane Res; 1980; 7():927-31. PubMed ID: 7369057
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of slow reacting substance of anaphylaxis (SRS-A) in plasma of guinea pigs during anaphylaxis.
    Stechschulte DJ; Orange RP; Austen KF
    J Immunol; 1973 Nov; 111(5):1585-9. PubMed ID: 4126780
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacologic analysis of two novel inhibitors of leukotriene (slow reacting substance) release.
    Fleisch JH; Haisch KD; Spaethe SM; Rinkema LE; Cullinan GJ; Schmidt MJ; Marshall WS
    J Pharmacol Exp Ther; 1984 Jun; 229(3):681-9. PubMed ID: 6202867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of arachidonic acid in the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) from sensitized guinea pig lung fragments: evidence that SRS-A is very similar or identical structurally to nonimmunologically induced forms of SRS.
    Watanabe-Kohno S; Parker CW
    J Immunol; 1980 Aug; 125(2):946-55. PubMed ID: 6104681
    [No Abstract]   [Full Text] [Related]  

  • 17. C5a-induced tracheal contraction: effect of an SRS-A antagonist and inhibitors of arachidonate metabolism.
    Regal JF; Pickering RJ
    J Immunol; 1981 Jan; 126(1):313-6. PubMed ID: 7451973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of indomethacin on leukotriene-induced contractile responses in guinea pig trachea and lung parenchyma strips].
    Uchida Y; Ishihara Y; Kitamura S; Takaku F
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Oct; 22(10):885-9. PubMed ID: 6530854
    [No Abstract]   [Full Text] [Related]  

  • 19. Slow-reacting substance of anaphylaxis--leukotrienes.
    Lancet; 1980 Jun; 1(8180):1226-7. PubMed ID: 6104041
    [No Abstract]   [Full Text] [Related]  

  • 20. Slow reacting substances: comparison of some properties of human lung SRS-A and two distinct fractions from ionophore-induced rat mononuclear cell SRS.
    Bach MK; Brashler JR; Brooks CD; Neerken AJ
    J Immunol; 1979 Jan; 122(1):160-5. PubMed ID: 762414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.